Frazier Healthcare Partners is a healthcare private equity and venture capital firm based in Seattle, Washington with offices in Menlo Park, California that invests across the U.S., Canada and Europe.[1] The firm specializes in leveraged buyouts, growth equity and venture capital financing.[2]
 | |
| Company type | Private |
|---|---|
| Industry | Private equity |
| Founded | 1991 |
| Founder | Alan D. Frazier |
| Headquarters | Two Union Square, , |
Key people | Alan D. Frazier (Chairman) |
| Products | |
| AUM | US$4.8 billion (2022) |
| Website | frazierhealthcare |
Background edit
Frazier Healthcare Partners was founded by Alan D. Frazier in 1991. With over $7.1 billion total capital raised, the firm has invested in over 200 companies and currently manages a portfolio of approximately 40 companies across healthcare services and life sciences sectors.[3]
The firm’s Growth Buyout fund invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences fund invests in therapeutics and related areas that are addressing unmet medical needs through innovation.[4]
In 2021, the investment firm closed its 10th dedicated healthcare fund focused on middle market companies, which was oversubscribed and hit its hard cap of $1.4 billion in total capital commitments.[5]
References edit
- ^ "Company Overview of Frazier Healthcare Partners". Bloomberg Business. Retrieved February 13, 2016.
- ^ "Frazier Healthcare Partners: Private Company Information - Bloomberg". www.bloomberg.com. Retrieved 2017-07-12.
- ^ "AUM". Frazier Management LLC. Retrieved May 19, 2022.
- ^ "Firm Overview, Growth Buyout and Life Sciences". 2022.
- ^ "Frazier Healthcare Partners Closes Oversubscribed $1.4 Billion Growth Buyout Fund". Reuters. 2021. Retrieved 2021-05-27.